CLINICAL_TRIALS trial_result · 2018-12-31

Clinical Trial Update: Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

Phase 3 efficacy study of nebulized TD-4208 for chronic obstructive pulmonary disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Mylan Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2018-12-31